OpenVigil 1 and 2 are software packages to analyse pharmacovigilance data. There are several national and international databases of so called spontaneous adverse event reports, e.g., the U.S. american FDA Adverse Event Reporting System (AERS, mostly domestic data) or the WHO Uppsala Monitoring Centre (international). Currently, analyses of FDA AERS (LAERS & FAERS) pharmacovigilance data are available. Data mining features include highly configurable search criteria filters and output filters. Analyses include disproportionality analyses like Proportional Reporting Ratio (PRR) calculations. Results can be viewed, sorted and filtered in the webbrowser or saved for further analyses in statistical software packages. Both projects aim at integrating these and other pharmacolovigilance sources to pharmacoepidemiological data like prescription data.Where can I access OpenVigil?
There are live installations of both versions of OpenVigil freely
available at Christian Albrecht University (CAU) of Kiel, Germany:
OpenVigil 2: http://www.is.informatik.uni-kiel.de:8503/OpenVigil/search/
(currently requires prior registration, please email us!)
(If you cannot reach the application, make sure that port 8503 is not blocked by your institution or internet provider.)
OpenVigil 1: http://www.uni-kiel.de/pharmacology/pvt/openvigil.php
(development version at: http://www.uni-kiel.de/pharmacology/pvt/openvigil-current.php)
OpenVigil 2 is the successor of OpenVigil 1 and uses cleansed FDA AERS data. For scientific research, do not use OpenVigil 1 but only version 2!
The project is maintained by Dr. R. Böhm, Institute of
Experimental and Clinical Pharmacology, UKSH Kiel, <email@example.com>
and Prof. H.J. Klein, Institut für Informatik, Christian Albrechts
University, Kiel, <firstname.lastname@example.org>
Both OpenVigil 1 and 2 use browser cookies.
Responsible for this website (Impressum / Betreiber der Website): Dr. med. Ruwen Böhm, Institut für Experimentelle und Klinisch Pharmakologie, UKSH Kiel, Hospitalstr. 4, 24105 Kiel, Germany. Tel. +49 431 597 3510.